Skip to main content
. 2019 Aug 2;9:11286. doi: 10.1038/s41598-019-47802-4

Figure 6.

Figure 6

Sensitivity analysis showing (A) anti-CTL-4, (B) anti-PD-1, and (C) anti-PD-L1 sensitivities relative to average tumor diameter (top row); in heatmap form to average tumor diameter, max effector T cell density in tumor and average mAPC density in the lymph nodes (second row); and representations of diversity in types of responses with variation in sensitivity analysis parameters, respectively for each column.